A total of 3 institutions have reported a stake in Fennec Pharmaceuticals Inc. (NASDAQ:FENC) as of December 2025, according to recent 13F filings with the SEC.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Southpoint Capital Advisors LP | 30 Sep, 2025 | 4,077,214 | 0 | 0.00% | $38,162,723.00 |
| Solas Capital Management, LLC | 30 Sep, 2025 | 2,187,902 | -45,000 | -2.02% | $20,478,763.00 |
| Rosalind Advisors, Inc. | 30 Sep, 2025 | 2,076,840 | 31,196 | 1.52% | $19,439,222.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 1,211,806 | -14,631 | -1.19% | $11,342,505.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 955,764 | -11,328 | -1.17% | $8,945,951.00 |
| AIGH Capital Management LLC | 30 Sep, 2025 | 681,501 | 229,101 | 50.64% | $6,378,850.00 |
| STATE STREET CORP | 30 Sep, 2025 | 341,201 | 4,707 | 1.40% | $3,193,641.00 |
| TANG CAPITAL MANAGEMENT LLC | 30 Sep, 2025 | 334,593 | 314,066 | 1,530.01% | $3,131,790.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 300,772 | -3,825 | -1.26% | $2,815,225.00 |
| MORGAN STANLEY | 30 Sep, 2025 | 232,402 | -21,816 | -8.58% | $2,175,283.00 |
| HARBERT FUND ADVISORS, INC. | 30 Sep, 2025 | 177,815 | -109,799 | -38.18% | $1,664,348.00 |
| GENDELL JEFFREY L | 30 Sep, 2025 | 139,559 | -147 | -0.11% | $1,306,272.00 |
| NORTHERN TRUST CORP | 30 Sep, 2025 | 130,553 | -919 | -0.70% | $1,221,976.00 |
| Lion Point Capital, LP | 30 Sep, 2025 | 123,000 | -72,700 | -37.15% | $1,151,280.00 |
| CITADEL ADVISORS LLC | 30 Sep, 2025 | 107,496 | 107,496 | 0.00% | $1,006,163.00 |
| JANE STREET GROUP, LLC | 30 Sep, 2025 | 72,631 | 22,642 | 45.29% | $679,826.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 30 Sep, 2025 | 57,249 | -4,038 | -6.59% | $535,851.00 |
| Bank of New York Mellon Corp | 30 Sep, 2025 | 52,278 | 466 | 0.90% | $489,325.00 |
| Hartford Financial Management Inc. | 30 Sep, 2025 | 50,646 | 0 | 0.00% | $474,047.00 |
| RHUMBLINE ADVISERS | 30 Sep, 2025 | 33,522 | -375 | -1.11% | $313,757.00 |